WO2004046315A3 - Compositions and methods utilizing human gamma-hydroxybutyrate receptor - Google Patents

Compositions and methods utilizing human gamma-hydroxybutyrate receptor Download PDF

Info

Publication number
WO2004046315A3
WO2004046315A3 PCT/US2003/036200 US0336200W WO2004046315A3 WO 2004046315 A3 WO2004046315 A3 WO 2004046315A3 US 0336200 W US0336200 W US 0336200W WO 2004046315 A3 WO2004046315 A3 WO 2004046315A3
Authority
WO
WIPO (PCT)
Prior art keywords
receptor
hghb
compositions
chemical
methods utilizing
Prior art date
Application number
PCT/US2003/036200
Other languages
French (fr)
Other versions
WO2004046315A8 (en
WO2004046315A2 (en
Inventor
Michel Maitre
Cauter Eve Van
Christian Andriamampandry
Jean Paul Humbert
Omar Taleb
Original Assignee
Slowave Inc
Michel Maitre
Cauter Eve Van
Christian Andriamampandry
Jean Paul Humbert
Omar Taleb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slowave Inc, Michel Maitre, Cauter Eve Van, Christian Andriamampandry, Jean Paul Humbert, Omar Taleb filed Critical Slowave Inc
Priority to AU2003290797A priority Critical patent/AU2003290797A1/en
Publication of WO2004046315A2 publication Critical patent/WO2004046315A2/en
Publication of WO2004046315A8 publication Critical patent/WO2004046315A8/en
Publication of WO2004046315A3 publication Critical patent/WO2004046315A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Abstract

The present invention concerns compositions and methods related to isolating and using human GHB receptors (hGHB receptor), as well as agents that modify the physical, chemical, and biological properties or activities of hGHB receptors. Isolation of an hGHB receptor and the polynucleotide(s) encoding an hGHB receptor allow the use of biotechnological approaches to screen for and identify compounds that affect or modulate receptor activity. Compounds identified will typically have advantageous properties such as stimulation, enhancement, or induction of SWS; biologic, chemical, and/or storage stability; less toxicity; higher potency; higher selectivity; fewer side effects and/or other beneficial physical, biological and pharmacologic characteristics.
PCT/US2003/036200 2002-11-14 2003-11-14 Compositions and methods utilizing human gamma-hydroxybutyrate receptor WO2004046315A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003290797A AU2003290797A1 (en) 2002-11-14 2003-11-14 Compositions and methods utilizing human gamma-hydroxybutyrate receptor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42619002P 2002-11-14 2002-11-14
US60/426,190 2002-11-14

Publications (3)

Publication Number Publication Date
WO2004046315A2 WO2004046315A2 (en) 2004-06-03
WO2004046315A8 WO2004046315A8 (en) 2004-08-26
WO2004046315A3 true WO2004046315A3 (en) 2004-11-18

Family

ID=32326319

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/036200 WO2004046315A2 (en) 2002-11-14 2003-11-14 Compositions and methods utilizing human gamma-hydroxybutyrate receptor

Country Status (2)

Country Link
AU (1) AU2003290797A1 (en)
WO (1) WO2004046315A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080274A (en) * 1968-08-20 1978-03-21 American Can Company Photopolymerization of lactone-epoxide mixtures with aromatic diazonium salts as photocatalyst
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080274A (en) * 1968-08-20 1978-03-21 American Can Company Photopolymerization of lactone-epoxide mixtures with aromatic diazonium salts as photocatalyst
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CASTELLI ET AL: "Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 446, no. 1-3, 20 June 2002 (2002-06-20), pages 1 - 5, XP002982117 *

Also Published As

Publication number Publication date
AU2003290797A1 (en) 2004-06-15
AU2003290797A8 (en) 2004-06-15
WO2004046315A8 (en) 2004-08-26
WO2004046315A2 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
WO2006004741A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2006004684A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
NO20070091L (en) Sugar coating and method for this
MXPA03006666A (en) Trisubstituted carbocyclic cyclophilin binding compounds and their use.
EA200601555A1 (en) Substituted indazole-glucosides
PA8637601A1 (en) MODULATING COMPOUNDS OF C-KIT ACTIVITY AND USES OF THE SAME
EA200601554A1 (en) SUBSTITUTED INDOL-O-GLUCOSIDES
WO2004087758A3 (en) Il 13 receptor alpha 2 antibody and methods of use
SV2008002972A (en) COMPOSITIONS, METHODS AND USES OF HUMAN ANTIBODIES ANTI-IL-23 REF. CEN5117SV
MXPA06011046A (en) Certain triazole-based compounds, compositions, and uses thereof.
WO2003029262A3 (en) The human mob-5 (il-24) receptors and uses thereof
UA86042C2 (en) Substituted indazole-o-glucosides
AU2003228770A1 (en) Substituted pyrazolopyrimidines
WO2007072201A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
MXPA06003363A (en) Phenyl-piperazine derivatives as modulators of muscarinic receptors.
WO2006078853A3 (en) Thioredoxin interacting protein (txnip) as regulator of vascular function
WO2005072290A3 (en) Methods of treating, reducing, or preventing autoimmune conditions
HRP20050336A2 (en) Substituted tetralins and indanes and their use
EA200601220A1 (en) ANTI-TRKC ANTIBODY-AGONISTS AND METHODS OF THEIR APPLICATION
HK1052026A1 (en) Human enzymes of the metalloprotease family
WO2004046315A8 (en) Compositions and methods utilizing human gamma-hydroxybutyrate receptor
DK1007666T3 (en) Neurturin
ATE314396T1 (en) G-CSF RECEPTOR AGONIST ANTIBODIES AND METHOD FOR ISOLATION SAME BY SCREENING
IL177915A0 (en) Fluorescence polarization assay
DE60142984D1 (en) HUMAN SPECIMENS SERIN / THREONINE KINASE

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 23/2004 UNDER (63) REPLACE "24 NOVEMBER 2002 (24.11.2002)" BY "14 NOVEMBER 2002 (14.11.2002)"

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC. ( THE EPO COMMUNICATION FORM 1205A HAS BEEN SENT ON 14-09-2005)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP